Whitepaper: Analytical testing considerations for ATMPs
This whitepaper discusses the analytical testing considerations for complex biological materials in ATMPs.
RSSL presents “Analytical testing considerations for complex biological materials in ATMPs”. This whitepaper aims to promote an understanding of the analytical landscape for testing complex biological raw materials in advanced therapy medicinal products (ATMPs) and how a Contract Research Organisation can help to facilitate the characterisation of raw materials within production processes.
It will also consider GMP requirements, potential testing approaches and relevant European regulations.
Related content from this organisation
Analytical techniques, Biologics, Biopharmaceuticals, Bioprocessing, Biosimilars, Excipients, Formulation, Gene therapy, Good Manufacturing Practice (GMP), Ingredients, Manufacturing, Outsourcing, Proteomics, QA/QC, Regulation & Legislation, Research & Development (R&D), Supply Chain, Vaccines